Business Combinations - Purchase Price Allocation (Details) - USD ($) $ in Thousands |
6 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Apr. 18, 2021 |
Jun. 30, 2022 |
|
| Statement [Line Items] | |||
| Cash | $ 7,650 | ||
| Working capital, paid in cash | 325 | ||
| Contingent consideration, paid in cash | 750 | ||
| Total - consideration | 8,725 | ||
| FilAMed | |||
| Statement [Line Items] | |||
| Cash | 1,400 | ||
| Working capital, paid in cash | 0 | ||
| Contingent consideration, paid in cash | 0 | ||
| Total - consideration | 1,400 | ||
| OB Healthcare | |||
| Statement [Line Items] | |||
| Cash | $ 400 | $ 6,100 | 6,250 |
| Working capital, paid in cash | 325 | ||
| Contingent consideration, paid in cash | 750 | ||
| Total - consideration | $ 7,325 |
| X | ||||||||||
- Definition Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|